Prognostic value of post-surgery liquid biopsy cell-free circulating tumor DNA in stage III colon cancer patients - PLCRC-PROVENC3 study | Labcorp Oncology Skip to main contentScroll Back to Top
Our global life sciences company brings diagnostic testing & drug development together.